Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FK4FE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,196
Award facts
- Contract value 100% obligated
- $14,196.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,196.38 for Wegovy 2.4 mg/0.75 mL pen injections on September 11, 2025, with completion targeted for September 12, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive federal contracting relationships focused on supplying medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal portfolio demonstrates consistent capability to deliver diverse pharmaceutical products across multiple therapeutic domains through competitively awarded contracts. This specific delivery order for Wegovy—a GLP-1 receptor agonist medication used for weight management—reflects the contractor's role in supporting military healthcare needs for specialized pharmaceutical products alongside its broader inventory of brand-name and generic medications, vaccines, and medical devices.
Quick answers
Who was awarded contract SPE2DB25FK4FE?
SPE2DB25FK4FE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FK4FE worth?
The government has obligated $14,196 on SPE2DB25FK4FE.
Is contract SPE2DB25FK4FE an order under another contract?
Yes. SPE2DB25FK4FE is a delivery order under SPE2DB22D3019, an indefinite delivery contract.
Was contract SPE2DB25FK4FE competed?
The extent of competition for SPE2DB25FK4FE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award